Whether you're dealing with skin concerns, tangled hair, or slightly embarrassing bodily issues — this lineup of gems will ...

Barclays raised the firm’s price target on Abbott (ABT) to $149 from $143 and keeps an Overweight rating on the shares. After rallying on the heels of the favorable jury verdict last week, the firm ...

Marie Thibault, an analyst from BTIG, reiterated the Buy rating on Abbott Laboratories (ABT – Research Report). The associated price ...